10:17 AM EST - Immunovaccine Inc. : reported a net loss of $1.7 million for the nine months ended December 31, 2009. The company reported revenues of $1.4 million during the nine months ended December 31, 2009. Revenues earned were through the company's animal health-care activities. Immunovaccine Inc.
shares V.IMV are trading even at $1.25.
